Consistent with previous reports, the anti-PD1 partially reduced WT tumor size/growth (Figure 6E) but remarkably, and within the same animals, eliminated the SHARPIN-deficient tumors (Figure 6, E–G), demonstrating synergism. The gene discussed is SHARPIN; the disease is neoplasm.